Home NDC 0310-0095-95 Daliresp
Product NDC 0310-0095
Requested package NDC 0310-0095-95
11-digit product format 003100095
Labeler code 0310
Product ID 0310-0095_11cd495f-c5cf-4076-b69c-af202ec2a8a1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name roflumilast
Dosage form TABLET
Route ORAL
Labeler AstraZeneca Pharmaceuticals LP
Application NDA022522
Marketing category NDA
Marketing start 2015-07-01
Substance ROFLUMILAST
Active strength 500 ug/1
Pharmacologic classes Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.
Historic NDC status page 1 of 1 · 2 matching rows.
Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0310-0095 0310-0095-95 D Discontinued by firm excluded / ndc_excluded.zip 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0310-0095 0310-0095-95 D Discontinued by firm excluded / ndc_excluded.zip 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022522-001 DALIRESP ROFLUMILAST 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 N022522-002 DALIRESP ROFLUMILAST 250MCG TABLET / ORAL AB RLD 2018-01-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022522-002 DALIRESP 250MCG TABLET / ORAL AB RLD 2018-01-23 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022522-002 DALIRESP 250MCG TABLET / ORAL RLD 2018-01-23 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022522-002 DALIRESP 250MCG TABLET / ORAL RLD 2018-01-23 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022522-002 DALIRESP 250MCG TABLET / ORAL RLD 2018-01-23 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022522-002 DALIRESP 250MCG TABLET / ORAL RLD 2018-01-23 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022522-002 DALIRESP 250MCG TABLET / ORAL RLD 2018-01-23 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022522-001 DALIRESP 500MCG TABLET / ORAL AB RLD, RS 2011-02-28 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022522-002 DALIRESP 250MCG TABLET / ORAL RLD 2018-01-23 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 68 observed states.
Observed Orange Book patent history# Patent history page 1 of 8 · 318 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-002 8604064 2024-03-08 U-1115 2018-03-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022522-002 8618142 2024-03-08 Drug product 2018-03-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-002 8604064 2024-03-08 U-1115 2018-03-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022522-002 8618142 2024-03-08 Drug product 2018-03-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-002 8604064 2024-03-08 U-1115 2018-03-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022522-002 8618142 2024-03-08 Drug product 2018-03-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-002 8604064 2024-03-08 U-1115 2018-03-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022522-002 8618142 2024-03-08 Drug product 2018-03-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022522-002 8604064 2024-03-08 U-1115 2018-03-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022522-002 8618142 2024-03-08 Drug product 2018-03-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-002 8604064 2024-03-08 U-1115 2018-03-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022522-002 8618142 2024-03-08 Drug product 2018-03-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022522-001 8536206 2024-03-08 U-1115 2013-10-15 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022522-001 8604064 2024-03-08 U-1115 2014-01-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022522-001 8618142 2024-03-08 Drug product 2014-01-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022522-002 8536206 2024-03-08 U-1115 2018-03-14 301d65b070ca…
Observed Orange Book exclusivity history# openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base Daliresp
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ROFLUMILAST 500 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0P6C6ZOP5U Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1091839 Internal RxNorm lookup 1091843 Internal RxNorm lookup 2001319 Internal RxNorm lookup 2001321 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0310-0095 DALIRESP (ROFLUMILAST) TABLET [ASTRAZENECA PHARMACEUTICALS LP] 14 Current NDC, Legacy NDC, 6 package rows 20241120_c9a1d0a8-581f-4f91-a2b8-f419192d0ebf.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0310-0095-95 00310009595 7 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0095-95) > 1 TABLET in 1 BLISTER PACK 7 blister pack 2015-07-01 0000-00-00 No No Current